Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States.
about
Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Cost-effectiveness of nivoluma ...... treated in the United States.
@en
Cost-effectiveness of nivoluma ...... treated in the United States.
@nl
type
label
Cost-effectiveness of nivoluma ...... treated in the United States.
@en
Cost-effectiveness of nivoluma ...... treated in the United States.
@nl
prefLabel
Cost-effectiveness of nivoluma ...... treated in the United States.
@en
Cost-effectiveness of nivoluma ...... treated in the United States.
@nl
P2093
P2860
P1476
Cost-effectiveness of nivoluma ...... a treated in the United States
@en
P2093
Justin Doan
Sukhvinder Johal
P2860
P2888
P356
10.1186/S40164-018-0095-8
P577
2018-02-09T00:00:00Z
P6179
1100914627